视神经脂质组学揭示青光眼中葡萄糖鞘氨醇脂质通路受损
研究比较人尸体供体对照(n=11)与原发性开角型青光眼(POAG;n=12)视神经的脂质谱,发现两组总脂质、总磷脂、总神经酰胺和总鞘脂无显著差异,但青光眼组葡萄糖鞘氨醇显著升高;青光眼组GBA和UGCG水平相似、GBA2降低、ASAH1和ASAH2升高,提示溶酶体和非溶酶体细胞区室的鞘脂酶通路可能受损。
要点
- 青光眼视神经葡萄糖鞘氨醇较对照显著升高,总脂质、总磷脂、总神经酰胺和总鞘脂无显著差异。
- 青光眼视神经GBA2降低、ASAH1和ASAH2升高,GBA和UGCG水平相似。
- 结果提示青光眼溶酶体和非溶酶体细胞区室的鞘脂酶通路可能受损。
核心结论
- 青光眼视神经中葡萄糖鞘氨醇脂质存在显著差异,与GBA和GBA2降低及ASAH1和ASAH2免疫反应性升高一致,提示溶酶体和非溶酶体细胞区室的鞘脂酶通路可能受损。
研究设计与样本
- 研究纳入人尸体供体视神经样本,对照n=11、原发性开角型青光眼(POAG)n=12;对照和青光眼供体均为白种人,年龄分别为72.3±5.9岁和70.3±10.5岁(含两性)。
- 采用Bligh和Dyer法提取脂质,称重组织后提取,并记录有机溶剂萃取对应水相中的蛋白量;使用Q-exactive质谱仪联用EASY-nLC 1000液相色谱仪进行高分辨率质谱分析。
- 使用LipidSearch v.4.1和MetaboAnalyst 4.0/STATA 14.2进行生物信息学和统计分析;采用Bradford法测定蛋白量。
- 采用既定方案进行Western blot、ELISA和免疫组化分别用于蛋白定量和定位;额外供体组织用于Western blot、ELISA和免疫组化。
主要发现
- 主成分分析(PCA)基于脂质谱分析将对照和青光眼视神经分为两个不同组。
- 对照与青光眼之间总脂质、总磷脂、总神经酰胺和总鞘脂相似(无显著差异)。
- 青光眼样本中葡萄糖鞘氨醇较对照样本显著升高。
- 青光眼视神经中葡萄糖脑苷脂酶(GBA)和神经酰胺葡萄糖基转移酶(UGCG)水平与对照相似,非溶酶体葡萄糖脑苷脂酶(GBA2)降低,溶酶体和非溶酶体酰基鞘氨醇酰胺水解酶(ASAH1和ASAH2)水平升高。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine major differences in lipid profile between human control and glaucomatous optic nerve. To assess major enzymes in lipid pathway if aberration is revealed for a lipid class by profiling. METHODS: Optic nerve (ON) samples were obtained from human cadaveric donors [control (n = 11) and primary open-angle glaucoma (POAG; n = 12)]; the lipids were extracted using Bligh and Dyer methods. Control and glaucoma donors were all Caucasians age 72.3 ± 5.9 and 70.3 ± 10.5 (inclusive of both sexes), respectively. Lipids were extracted after weighing the tissue; the protein amounts in the corresponding aqueous phase of organic solvent extraction were recorded. High-resolution mass spectrometry was performed using a Q-exactive mass spectrometer coupled with an EASY-nLC 1000 liquid chromatograph instrument. Bioinformatics and statistical analysis were performed using LipidSearch v.4.1 and MetaboAnalyst 4.0/STATA 14.2. Protein amounts were determined using Bradford's method. Western blot, ELISA, and immunohistochemistry utilized established protocols and were performed for protein quantification and localization, respectively. Additional donor tissues were utilized for Western blot, ELISA, and immunohistochemistry. RESULTS: Principal component analysis (PCA) placed control and glaucomatous ONs in two distinct groups based on analysis of lipid profiles. Total lipid, total phospholipids, total ceramide, and total sphingolipids were similar (without significant difference) between control and glaucoma. However, we found a significant increase in glucosylsphingosine in glaucoma compared to control samples. We found similar levels of glucocerebrosidase (GBA), ceramide glucosyltransferase (UGCG), decreased nonlysosomal glucocerebrosidase (GBA2), and increased lysosomal and nonlysosomal acylsphingosine amidohydrolase (ASAH1 and ASAH2) levels in glaucomatous ON compared to control. CONCLUSIONS: We found significant differences in glucosylsphingosine lipids, consistent with decreased GBA and GBA2 and increased ASAH1 and ASAH2 immunoreactivity in glaucoma, suggesting the potential impairment of sphingolipid enzymatic pathways in lysosomal and nonlysosomal cellular compartments.
引用
- Chauhan MZ, Valencia AK, Piqueras MC, et al. Optic Nerve Lipidomics Reveal Impaired Glucosylsphingosine Lipids Pathway in Glaucoma. Invest Ophthalmol Vis Sci. 2019. PMID: 31022733. doi:10.1167/iovs.18-25802
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。